Logo image of ONTEX.BR

ONTEX GROUP NV (ONTEX.BR) Stock Fundamental Analysis

EBR:ONTEX - Euronext Brussels - BE0974276082 - Common Stock - Currency: EUR

6.99  +0.02 (+0.29%)

Fundamental Rating

3

Taking everything into account, ONTEX scores 3 out of 10 in our fundamental rating. ONTEX was compared to 13 industry peers in the Personal Care Products industry. ONTEX has a bad profitability rating. Also its financial health evaluation is rather negative. ONTEX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

ONTEX had positive earnings in the past year.
ONTEX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ONTEX reported negative net income in multiple years.
ONTEX had a positive operating cash flow in each of the past 5 years.
ONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFONTEX.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.44%, ONTEX is doing worse than 69.23% of the companies in the same industry.
Looking at the Return On Equity, with a value of 1.11%, ONTEX is doing worse than 69.23% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.78%, ONTEX is doing worse than 69.23% of the companies in the same industry.
ONTEX had an Average Return On Invested Capital over the past 3 years of 4.39%. This is significantly below the industry average of 11.95%.
The 3 year average ROIC (4.39%) for ONTEX is below the current ROIC(6.78%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROIC 6.78%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ONTEX.BR Yearly ROA, ROE, ROICONTEX.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

ONTEX has a Profit Margin of 0.55%. This is in the lower half of the industry: ONTEX underperforms 69.23% of its industry peers.
ONTEX's Profit Margin has declined in the last couple of years.
The Operating Margin of ONTEX (7.98%) is worse than 76.92% of its industry peers.
In the last couple of years the Operating Margin of ONTEX has grown nicely.
The Gross Margin of ONTEX (29.23%) is worse than 84.62% of its industry peers.
In the last couple of years the Gross Margin of ONTEX has remained more or less at the same level.
Industry RankSector Rank
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
ONTEX.BR Yearly Profit, Operating, Gross MarginsONTEX.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ONTEX is creating some value.
The number of shares outstanding for ONTEX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ONTEX has more shares outstanding
ONTEX has a better debt/assets ratio than last year.
ONTEX.BR Yearly Shares OutstandingONTEX.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ONTEX.BR Yearly Total Debt VS Total AssetsONTEX.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that ONTEX is in the distress zone and has some risk of bankruptcy.
ONTEX's Altman-Z score of 1.31 is on the low side compared to the rest of the industry. ONTEX is outperformed by 84.62% of its industry peers.
ONTEX has a debt to FCF ratio of 6.97. This is a slightly negative value and a sign of low solvency as ONTEX would need 6.97 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.97, ONTEX is doing worse than 61.54% of the companies in the same industry.
ONTEX has a Debt/Equity ratio of 0.72. This is a neutral value indicating ONTEX is somewhat dependend on debt financing.
ONTEX has a Debt to Equity ratio of 0.72. This is comparable to the rest of the industry: ONTEX outperforms 46.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Altman-Z 1.31
ROIC/WACC1.09
WACC6.19%
ONTEX.BR Yearly LT Debt VS Equity VS FCFONTEX.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

ONTEX has a Current Ratio of 1.21. This is a normal value and indicates that ONTEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.21, ONTEX is in line with its industry, outperforming 46.15% of the companies in the same industry.
A Quick Ratio of 0.81 indicates that ONTEX may have some problems paying its short term obligations.
The Quick ratio of ONTEX (0.81) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.81
ONTEX.BR Yearly Current Assets VS Current LiabilitesONTEX.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

The earnings per share for ONTEX have decreased strongly by -72.09% in the last year.
The earnings per share for ONTEX have been decreasing by -23.62% on average. This is quite bad
ONTEX shows a small growth in Revenue. In the last year, the Revenue has grown by 3.67%.
Measured over the past years, ONTEX shows a decrease in Revenue. The Revenue has been decreasing by -4.00% on average per year.
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%

3.2 Future

Based on estimates for the next years, ONTEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.39% on average per year.
The Revenue is expected to grow by 3.66% on average over the next years.
EPS Next Y11.67%
EPS Next 2Y10.35%
EPS Next 3Y11.39%
EPS Next 5YN/A
Revenue Next Year3.29%
Revenue Next 2Y3.44%
Revenue Next 3Y3.66%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ONTEX.BR Yearly Revenue VS EstimatesONTEX.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
ONTEX.BR Yearly EPS VS EstimatesONTEX.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 58.25, which means the current valuation is very expensive for ONTEX.
Based on the Price/Earnings ratio, ONTEX is valued more expensive than 84.62% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.45. ONTEX is valued rather expensively when compared to this.
ONTEX is valuated cheaply with a Price/Forward Earnings ratio of 5.72.
Based on the Price/Forward Earnings ratio, ONTEX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
ONTEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 58.25
Fwd PE 5.72
ONTEX.BR Price Earnings VS Forward Price EarningsONTEX.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

92.31% of the companies in the same industry are more expensive than ONTEX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ONTEX is valued cheaply inside the industry as 92.31% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 5.57
EV/EBITDA 5.56
ONTEX.BR Per share dataONTEX.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.99
PEG (5Y)N/A
EPS Next 2Y10.35%
EPS Next 3Y11.39%

0

5. Dividend

5.1 Amount

ONTEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ONTEX GROUP NV

EBR:ONTEX (7/4/2025, 7:00:00 PM)

6.99

+0.02 (+0.29%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-30 2025-04-30
Earnings (Next)07-31 2025-07-31
Inst Owners38.76%
Inst Owner ChangeN/A
Ins Owners3.06%
Ins Owner ChangeN/A
Market Cap575.63M
Analysts80
Price Target10.85 (55.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.62%
PT rev (3m)-2.36%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.96%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.8%
Valuation
Industry RankSector Rank
PE 58.25
Fwd PE 5.72
P/S 0.31
P/FCF 5.57
P/OCF 2.67
P/B 0.62
P/tB 6.22
EV/EBITDA 5.56
EPS(TTM)0.12
EY1.72%
EPS(NY)1.22
Fwd EY17.48%
FCF(TTM)1.25
FCFY17.95%
OCF(TTM)2.62
OCFY37.47%
SpS22.59
BVpS11.24
TBVpS1.12
PEG (NY)4.99
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.44%
ROE 1.11%
ROCE 9.14%
ROIC 6.78%
ROICexc 7.02%
ROICexgc 15%
OM 7.98%
PM (TTM) 0.55%
GM 29.23%
FCFM 5.55%
ROA(3y)-2.71%
ROA(5y)-1.72%
ROE(3y)-8.84%
ROE(5y)-5.5%
ROIC(3y)4.39%
ROIC(5y)4.43%
ROICexc(3y)4.61%
ROICexc(5y)4.96%
ROICexgc(3y)9.94%
ROICexgc(5y)12.9%
ROCE(3y)5.92%
ROCE(5y)5.98%
ROICexcg growth 3Y14.1%
ROICexcg growth 5Y2.75%
ROICexc growth 3Y23.18%
ROICexc growth 5Y5.84%
OM growth 3Y8.65%
OM growth 5Y4.46%
PM growth 3YN/A
PM growth 5Y-19.47%
GM growth 3Y0.83%
GM growth 5Y1.47%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF 6.97
Debt/EBITDA 3
Cap/Depr 151.69%
Cap/Sales 6.04%
Interest Coverage 3.95
Cash Conversion 96.9%
Profit Quality 1002.91%
Current Ratio 1.21
Quick Ratio 0.81
Altman-Z 1.31
F-Score6
WACC6.19%
ROIC/WACC1.09
Cap/Depr(3y)125.61%
Cap/Depr(5y)112.58%
Cap/Sales(3y)5.05%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.09%
EPS 3YN/A
EPS 5Y-23.62%
EPS Q2Q%-71.21%
EPS Next Y11.67%
EPS Next 2Y10.35%
EPS Next 3Y11.39%
EPS Next 5YN/A
Revenue 1Y (TTM)3.67%
Revenue growth 3Y9.72%
Revenue growth 5Y-4%
Sales Q2Q%4.6%
Revenue Next Year3.29%
Revenue Next 2Y3.44%
Revenue Next 3Y3.66%
Revenue Next 5YN/A
EBIT growth 1Y43.9%
EBIT growth 3Y19.21%
EBIT growth 5Y0.28%
EBIT Next Year94.21%
EBIT Next 3Y29.88%
EBIT Next 5YN/A
FCF growth 1Y61.15%
FCF growth 3Y11.86%
FCF growth 5Y-5.23%
OCF growth 1Y34.31%
OCF growth 3Y18.3%
OCF growth 5Y-2.03%